EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Na+/K+-ATPase: A potential therapeutic target in cardiometabolic diseases

Milan Obradovic, Emina Sudar-Milovanovic, Zoran Gluvic, Katarina Banjac, Manfredi Rizzo, Esma R Isenovic

Frontiers in Endocrinology · 2023

DOI: 10.3389/fendo.2023.1150171 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Endocrinology, 2023. Verfasst von Milan Obradovic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiobiology and Molecular Genetics, "VINČA" Institute of Nuclear Sciences - National Institute of thе Republic of Serbia, University o…. Hauptthemen laut MEDLINE: Cardiac Glycosides, Cardiovascular Diseases. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiometabolic diseases (CMD) are a direct consequence of modern living and contribute to the development of multisystem diseases such as cardiovascular diseases and diabetes mellitus (DM). CMD has reached epidemic proportions worldwide. A sodium pump (Na + /K + -ATPase) is found in most eukaryotic cells’ membrane and controls many essential cellular functions directly or indirectly. This ion transporter and its isoforms are important in the pathogenesis of some pathological processes, including CMD. The structure and function of Na + /K + -ATPase, its expression and distribution in tissues, and its interactions with known ligands such as cardiotonic steroids and other suspected endogenous regulators are discussed in this review. In addition, we reviewed recent literature data related to the involvement of Na + /K + -ATPase activity dysfunction in CMD, focusing on the Na + /K + -ATPase as a potential therapeutic target in CMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac GlycosidesCardiovascular DiseasesHumansSodium-Potassium-Exchanging ATPaseCell Membrane

Stichwörter der Autor:innen

Na+/K+-ATPasecardiometabolic diseasescardiovascular diseasestherapytype 2 diabetes mellitus

Substanzen

Cardiac GlycosidesSodium-Potassium-Exchanging ATPase

Autor:innen und Institutionen

  • Department of Radiobiology and Molecular Genetics, "VINČA" Institute of Nuclear Sciences - National Institute of thе Republic of Serbia, University of Belgrade, Belgrade, Serbia.
  • University Clinical-Hospital Centre Zemun-Belgrade, Clinic of Internal medicine, School of Medicine, University of Belgrade, Belgrade, Serbia.
  • School of Medicine, Promise Department, University of Palermo, Palermo, Italy.

Zitieren

APA

Obradovic, M., Sudar-Milovanovic, E., Gluvic, Z., Banjac, K., Rizzo, M., & Isenovic, E. R. (2023). The Na+/K+-ATPase: A potential therapeutic target in cardiometabolic diseases. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2023.1150171

Vancouver

Obradovic M, Sudar-Milovanovic E, Gluvic Z, Banjac K, Rizzo M, Isenovic ER. The Na+/K+-ATPase: A potential therapeutic target in cardiometabolic diseases. Frontiers in Endocrinology. 2023. doi:10.3389/fendo.2023.1150171

BibTeX
@article{Obradovic2023,
  author = {Obradovic, Milan and Sudar-Milovanovic, Emina and Gluvic, Zoran and Banjac, Katarina and Rizzo, Manfredi and Isenovic, Esma R},
  title = {The Na+/K+-ATPase: A potential therapeutic target in cardiometabolic diseases},
  journal = {Frontiers in Endocrinology},
  year = {2023},
  doi = {10.3389/fendo.2023.1150171}
}
Kostenlos starten →